1
Q
- Lower the dose of _____, _____, _____ or _____ as H2 blockers may decrease their metabolism and enhance duration of action (slower recovery)
- _____ is a weak anti-androgenic: may produce _____ and _____ in males
- Contraindicated in _____ and _____
A
Diazepam Midazolam Lidocaine TCAs Cimetidine impotence gynecomastia pregnancy lactation
2
Q
NSAIDs
- NSAIDs are the most common cause of _____ in patients without _____ infection
- topical effects of NDAIDs cause submucosal _____. in addition, by inhibiting _____, NSAIDs inhibit the formation of _____ (PGE2) and their protective _____-2-mediated effects (i.e., enhancing gastric mucosal protection by stimulating _____ and _____ secretion and _____ proliferation and increasing mucosal _____)
- coexisting _____ infection increases the likelihood and intensity of NSAID- induced damage
- NSAID use is responsible for approximately one half of _____, which occur most commonly in older patients who are taking _____ or other _____ for _____ or _____
A
PUD H. Pylori submucosal erosions cyclooxygenase prostaglandins cyclooxygenase mucus bicarbonate epithelial cell blood flow H. Pylori
perforated ulcers aspirin NSAIDs cardiovascular disease arthropathy
3
Q
STEROID SPARING: Decrease the long-term need for steroids for recurring flares
- takes _____ months (slow onset of action) for improvement in symptoms, steroids are started at the same time to produce a faster response and are withdrawn rapidly
- oral: _____ (Azasan, Imuran )and _____ (Purinethol)
- used to maintain _____
- Other examples : _____ (weekly injections), _____ and _____ (Topical- for Pyoderma Gangrenosum)
A
3-6 Azathioprine 6-Mercaptopurine remission Methotrexate Cyclosporine A Tacrolimus
4
Q
ERADICATION OF H.PYLORI-DRUG COMBINATION THERAPY
-OAC – _____, _____, and _____ for _____ days;
BMT – _____, _____, and _____ for _____ days;
LAC – _____, _____, and _____ (LAC), for either _____ days or _____ days;
A
Omeprazole Amoxicillin Clarithromycin 10 Bismuth subsalicylate Metronidazole Tetracycline 14 lansoprazole Amoxicillin Clarithromycin 10 14
5
Q
SE of PPI
- Increased risk of _____ and _____
- A risk factor for _____ infection via alteration of the colonic flora
- Combination therapy: _____ + _____ + _____
- PPIs may reduce absorption of some _____ and _____ (require _____ environment for absorption)
- Decrease efficacy of _____ (PPIs inhibit CYP2C19 enzyme, thus interfering with the conversion of Clopidogrel into its active metabolite)
A
pneumonia bone fracture C. difficile Antacids H2 blockers PPIs antibiotics antifungals acidic Clopidogrel
6
Q
bulk forming
- _____
- _____
stimulants
- _____
- _____
osmotic
- _____
- _____
- _____ (_____)
- _____
wetting agents
- _____
- _____
A
Psyllium, Methylcellulose
Bisacodyl Senna, Castor oil
Mag hydroxide Lactulose, Glycerin Polyethylene glycol (PEG)
Milk of Magnesia
Docusate
Mineral oil
7
Q
CELIAC DISEASE (GLUTEN SENSITIVE ENTEROPATHY)
- Autoimmune disorder of _____ intestine in genetically predisposed (HLA DQ2, DQ8, or both)
- An inflammatory reaction to dietary gluten resulting in production of _____ that may produce _____ of the _____ (villous atrophy)
- Intestinal manifestations- _____, flatulance and weight loss.
- _____- iron deficiency anemia(palor), decreased bone mineral density, dermatitis herpetiformis, neuropathy and muscle wasting
- Left untreated- low _____ (vitamin D def) and risk for _____
- Women- risk of _____, spontaneous abortions, preterm deliveries, and LBW
A
small autoantibodies shortening villi diarrhea Extraintestinal BMD fractures infertility
8
Q
2: 5HT3 RECEPTOR ANTAGONISTS FOR IBS-D
- _____ (Zofran) – has excellent safety record
- _____ is present in the entero-chromaffin cells (EC cells)
- These patients have higher mucosal _____ concentrations in the colon
- Improve QOL by slowing transit, reducing bowel frequency, normalizing _____, and reducing _____
- Blocks _____ signals that transmit _____ information (painful and non painful) from the gut to the brain and helps to reduce _____ and abdominal pain.
- SE: _____ (25%) and _____
A
Ondansetron Serotonin 5-HT stool consistency urgency serotonin sensory diarrhea Constipation Ischemic colitis
9
Q
antacids: _____ + _____ = _____ + _____
- act as buffers to neutralize _____ (act within _____)
- therapeutic effect is by _____ or _____ properties
- salts of _____, _____, or _____
- available as chewable/dissolving tablets, liquid and gums
- examples: _____, _____, _____
- inhibit _____ activity by raising pH to _____
- side effects- _____ (_____ salts) and _____ (_____ salts)
- mixture of these two can preserve normal _____ function
- antacids impair the absorption of _____, oral _____, _____, _____, _____, _____ and _____
A
acid alkali salt water H+ ions mins physical chemical aluminum magnesium calcium alka-seltzer gelusil tums peptic 5 diarrhea Mg constipation Al bowel tetracycline iron fluoride ciprofloxacin erythromycin metronidazole thyroxine
10
Q
H2 blockers- inhibit _____ and _____ stimulated _____ secretion
- ________ ________ inhibitors of _____ at all H2- receptors
- highly selective for _____
- inhibit _____, _____, and _____ stimulated _____ secretion
- _____ secretion also falls with reduction in acid volume
- available both by OTC and prescription:
- _____ (Tazac, Axid)
- _____ (Pepcid)
- _____ (Zantac)
- _____ (Tagamet)
- _____ are likely to follow when treatment is stopped
- all agents are rapidly absorbed from _____
A
basal food gastric acid reversible competitive histamine H2 receptors histamine gastrin Ach acid pepsin Nizatidine Famotidine Ranitidine Cimetidine relapses intestine
11
Q
H. Pylori
- Gram _____, spiral bact, in _____ and _____
- Infection occurs by _____ route
- _____ cavity may be the permanent reservoir (found in dental plaque and saliva) and a _____ route is the most probable mode of transmission
- Several virulence factors are produced:
- _____
- this converts urea into _____ which buffers _____ and creates an _____ (allows to survive for years)
- Results in
- High levels of _____ and _____ and reduced levels of _____
- Impaired _____ secretion
A
–ve gastric antrum pyloric sphincter oral person-to-person Urease ammonia H+ ions ALKALINE CLOUD gastrin pepsinogen somatostatin duodenal bicarbonate
12
Q
treatment
- _____-free diet (Dietary education should focus on identifying hidden sources of gluten, planning balanced meals, reading labels, food shopping, dining out, and dining during travel)
- 5% of patients are refractory to a gluten-free diet
- Refractory patients –
- -_____
- -_____
- -Remission may be induced by the _____ and maintained with _____ and _____.
- Dermatitis herpetiformis – _____ skin ointment, _____ or potent topical Steroids (_____ or _____) or very potent (_____)
A
Gluten Corticosteroids Immuno-modulators anti-TNF alpha antibody Infliximab Prednisolone Azathioprine Dapsone Salfasalazine Betamethasone valerate dipropionate Clobetasol propionate
13
Q
GERD: a digestive disorder of the _____ (_____)
- symptoms: chronic _____, _____, _____, _____ pain and early _____
- Reflux – Excess _____ production, weakness of _____ at LES or _____
- > 9 million primary care visits annually in US
- Most common cause of _____
- If left untreated, esophagitis can cause _____, _____, and chronic _____
- Scarring narrows the esophagus and interferes with _____
- Long standing GERD symptoms may cause _____ (10-15%) increasing the likelihood of _____
A
lower esophageal sphincter (LES) heartburn dyspepsia regurgitation epigastric satiety acid muscular ring hiatal hernia esophagitis bleeding ulcers scarring swallowing Barrett's esophagus cancer
14
Q
STEP III-IMMUNOMODULATORS (Steroid-Sparing drugs)
- MOA: inhibit _____ mediated and _____ mediated immune reactions- _____
- inhibit _____, _____ and _____ of cells
- used if:
- -No-response or intolerance to _____, _____ or _____
- -_____ disease or frequent need for steroids
- -Perianal disease that does not respond to _____
- -_____
- -To bolster the effect of a _____ drug and prevent the development of resistance to biologic drugs
- -Prevent recurrence after surgery
A
cell antibody immunosuppressants production differentiation proliferation Amino-salicylates antibiotics corticosteroids Steroid-dependent Antibiotics fistulas biologic
15
Q
CD- oral manifestations
- Seen on _____, _____ mucosa and _____
- _____ ulcerations
- Angular _____
- _____ with or without edema of lips
- Mucosal _____ in the gingiva
- Buccal mucosa _____
A
lips buccal gingiva Aphthous cheilitis Cobblestoning tags abscesses
16
Q
CLINICIAN’S CONCERNS drug induced: -\_\_\_\_\_ -\_\_\_\_\_ disturbance -\_\_\_\_\_
-may decrease _____ effect of the anticoagulants like _____ and _____
A
agranulocytosis taste parotitis anticoagulant heparin warfarin
17
Q
OPIOID RECEPTOR ANTAGONISTS – µ (peripheral)
- _____
- Used in short term tt of opioid _______ without affecting analgesia and withdrawals
A
Methynaltrexone
induced constipation
18
Q
antiemetics
-_____ – Benzodiazepines like lorazepam
-_____ – Antipsychotics like _____, Prochlorperazine
-D2 antagonists in CTZ and peripheral pro-kinetic action – _____ and _____
-_____ – Ondansetron, Granisetron
_____ is highly selective, high-affinity, non cardiotoxic and safe in children
-_____ – Meclizine, Cinnarizine, Cyclizine, Dimenhydrinate, Promethazine and Diphenhydramine
-Muscarinic antagonists– _____( Scopolamine as a transdermal patch)
-Corticosteroid combination and neurokinin 1 (NK1) receptor antagonist – Aprepitant
-Partial CB1 agonist – _____ and _____
A
GABA agonist DA antagonists Promethazine Metoclopramide Domperidone 5HT3 antagonist Granisetron H1 antagonists Hyoscine nabilone, dronabinol
19
Q
ALARM FEATURES” that warrant prompt gastroenterology referral
- _____
- _____
- early _____
- unexplained _____
- progressive _____ or _____
- recurrent vomiting and family history of _____
-patients with perforated PUD usually present with a sudden onset of severe, sharp _____ pain: _____!
A
bleeding anemia satiety weight loss dysphagia odynophagia GI cancer abdominal medical emergency
20
Q
ANALGESIC OF CHOICE IN PUD AND IBD PATIENTS
- Avoid prescribing _____ and _____
- Use _____ or _____ (selective COX-2inhibitor) in combination with _____ or _____
- IBD pt – avoid long term use of _____, especially in elderly and debilitated to minimize risk of _____
- Monitor for signs and symptoms of _____
- Selection of antibiotics for oral infections may be influenced by recent use of antibiotics for _____
A
Aspirin NSAIDs Acetaminophen Celecoxib PPI Misoprostal antibiotics pseudomembranous colitis diarrhea PUD
21
Q
MANAGEMENT1: OPIOIDS FOR IBS-D
- _____ (Imodium) - binds to the _____ receptor in the gut wallConsequently, inhibiting the release of _____ and _____, thereby reducing _____, and increasing intestinal transit time.
- Improves QOL as it allows planning of trips and socializing- anxious IBS-D patients
- Maximum daily dose is 8mg for adults as OTC use and 16mg as prescription use.
- Much higher doses can cause _____ and even death.
A
Loperamide opiate Ach PGs peristalsis cardiotoxicity
22
Q
COLLOIDAL BISMUTH COMPOUNDS-Indirectly inhibit acid secretion
- Suppress _____ infection and reduce the hypersecretion of _____
- Form an _____ over the ulcer base preventing further damage by acid and pepsin- _____ drug mechanism
- Adverse effects: _____ of the _____ and darkening of the _____
- No significant drug interactions
- Available as _____, _____
A
H. pylori acid insoluble protective layer Physical blackening stool tongue Pepto-Bismol Kaopectate
23
Q
GASTRITIS: inflammation, irritation or erosion of _____
- acute/chronic
- causes:
- -excessive _____ use
- -chronic _____
- -_____
- -medications such as _____, other _____ and _____
- ______
- _____ reflux
- infections caused by _____ and _____
- if left untreated- severe loss of _____ and increased risk of developing _____
A
stomach lining alcohol vomiting stress aspirin NSAIDs bisphosphonates H. pylori bile bacteria viruses blood stomach cancer
24
Q
3: SECRETAGOGUES FOR IBS-C
-Guanylate cyclase-C receptor agonist: Stimulates _____ secretion by activation of type 2 _____ via _____ (an intracellular second messenger) which in turn promotes _____
–_____ (Amitiza)- does not alter pain thresholds during rectal distension, acts on ____ receptors stimulating chloride receptors, _____ take care of pain
–_____ (Linzess) - improves pain as well by blocking pain signals, works on _____ channels, stimulating chloride receptors, takes care of pain
SE: _____
A
chloride Cl- ion channels cGMP peristalsis Lubiprostone GCC does not Linaclotide chloride 2 Diarrhea
25
COMMON SIDE EFFECTS WITH IMMUNOSUPPRESSANT DRUGS
- _____ and _____: Canker sores, bone marrow suppression (increase the risk of infection or serious ______) and increased risk of ____________
- _____ and _____: increased risk of infections, high blood pressure, swollen _____, tingling of the fingers and feet, increased _____
- _____: Severe mouth sores and low ___ count. Addition of ______ may reduce some side effects.
```
Azathioprine
6MP
bleeding
non-hodgkins lymphoma
Cyclosporine
tacrolimus
gums
facial hair
Methotrexate
WBC
folic acid
```
26
SUCRALFATE
- A salt of sucrose complexed to sulfated _______
- MOA: Similar to ______ compounds
- SE: _____
- Contraindicated in _____ because of the risk of _____ absorption and toxicity
- Drug interactions: Can reduce the absorption of drugs such as _____ and _____
- Available as _____
```
Aluminum hydroxide
bismuth
Constipation
chronic renal failure
Aluminum
Phenytoin
Tetracycline
Carafate
```
27
laxative abuse
- Eating disorders – _____ (binge eating followed by purging)
- Quick weight control – _____ (boxing, wrestling)
- _____ – something is wrong if they don't move their bowels every day
Bulimia
Combat sports
Older adults
28
STEP IV: BIOLOGIC THERAPY WITH MONOCLONAL ANTIBODIES
- _____: If not responded or intolerant to Corticosteroid and/or an Immunosuppressant
- -_____ (IV) – Remicade
- -_____ (SC) – Humira
- -_____ – Cimzia
- TNF is a _____ agent in the body's immune response and is _____ in IBD
- Watch-out for reactivation of latent _____ and other opportunistic infections, _____
- Cautious use in pts with _____
```
Tumor necrosis factor (TNF) inhibitors
Infliximab
Adalimumab
Certolizumab pegol
cytokine
upregulated
TB
Hepatitis B
heart failure
```
29
treatment of oral lesions
- Local _____ injections to the lesion
- _____ 2% in severe cases
- Topical _____ at low concentrations of 0.5 mg/kg
- 1% _____ ointment three times daily
- Steroid _____ (Dexamethasone elixir)
- Topical _____ ointment for refractory aphthous ulcers
```
Corticosteroid
Lidocaine
Tacrolimus
Hydrocortisone
mouthwashes
Dexamethasone
```
30
MISOPROSTOL – A synthetic PGE1 analog
- Has _____ inhibitory and _____ protective properties
- Simulates _____ and _____ secretion and enhance mucosal blood flow
- Binds to a _____ receptor on parietal cells, reducing _____ mediated ____production
- Is an _____ drug (stimulates uterine contraction), so not to be used during pregnancy
- No significant drug interactions are reported
- Available as _____, _____
```
acid inhibitory
mucosal
mucus
bicarbonate
prostaglandin
histamine, c-AMP
abortifacient
Cytotec
Misodel
```
31
management
- Bulk forming – Absorb _____ and _____ to increase _____ pressure (increase in peristalsis)
- Stimulants – Stimulate _____ in intestinal smooth muscle, increase mucosal permeability (moves fluids into lumen)
- Osmotics – Increase _____ (stimulate peristalsis by increasing intraluminal pressure)
- Wetting agents – _____ to ease passage (act like detergents and soften stools by reducing _____, thus allowing intestinal fluids, fatty substances to penetrate fecal mass)
```
water
expand
intraluminal
enteric nerves
fluid volume
Moisten
surface tension
```
32
STEP II- CORTICOSTEROIDS(ANTI-INFLAMMATORY)
- For _____ disease flares only
- Decrease inflammation by reversing increased capillary _____ and suppressing _____ activity
- Not effective in preventing complications or progression of disease
- ___-term use is discouraged due to side effects
- _____ and _____ Prep (Suppositories, enemas and rectal foams)
- -_____ (O)
- -_____ (O, Top)
- -_____ (O, Inj)
- -_____ (O, Top) an enteric-coated controlled-release capsule delivers active _____ to the distal _____ and _____
```
acute
increased capillary permeability
PMN
Oral
rectal
Prednisone
hydrocortisone
methylprednisone
budesonide
glucocorticoid
distal small intestine
colon
```
33
constipation
- 74% nursing home residents
- _____, lack of _____, or use of certain medications (_____, _____, _____, _____, _____ and Supplements like _____/_____)
- Underlying ds- Stroke, Parkinson's disease, Diabetes, Spinal cord injury, Multiple sclerosis, Hypothyroidism etc
- Most pts use OTC remedies and don't report
- Discomfort, bloating, hemorrhoids or fecal impaction
- Mistaken belief: everyone should move their bowels each day, can lead to dangerous _____ overuse
- Bowel movements _____/wk may be normal and healthy for some
```
Diet
physical activity
Opioids
CCBs
diuretics
antidepressants
antacids
iron/calcium
laxative
3
```
34
PUD: peptic ulcer disease (gastric/duodenal)
| -_____ that develops on the _____ lining of the stomach and or the _____ portion of _____ (extends through _____ mucosa)
```
open sore
inside
upper
SI
muscularis
```
35
- _____: inflammation of superficial gastric mucosa
- _____: destruction of multiple small zones of superficial mucosa
- _____: destruction of full thickness of mucosa
superficial gastritis
erosive gastritis
gastric ulceration
36
TRAVELLER’S DIARRHEA
- Acute diarrhea in those who travel to developing countries and have adventuresome _____ behavior
- Main source of infection: Food and water contaminated with _____ matter
- Bacteria: _____, Campylobacter, _____, and Shigella
- Luxury resorts & cruise ships (_____ virus)
- Seafood ingestion syndromes : _____ numbness and reversal of _____ sensation
- More susceptible: Immunocompromised or lowered _____ (e.g., on _____ or _____)
```
eating
fecal
E coli
Salmonella
Noro
Perioral
temperature
gastric acidity
H2blockers
PPIs
```
37
MANAGEMENT- Stepwise approach (step-up)
- Step I – 5-ASA (_____) _____ daily basis (life long maintenance)
- -_____-Pentasa, Rowasa, Asacol
- -_____ – Azulfidine
- -_____ – Giazo
- MOA: exert topical _____ effect by reduction in synthesis of inflammatory _____ (inhibition of _____ production, blocking of _____)
- Side effects: _____, Vomiting and GI upset (poor compliance), _____ discoloration of secretions, decrease in _____ absorption (supplements, megaloblastic anemia)
- Used during flares and for maintaining _____
- Overall: safe, well-tolerated but drug _____ is very imp
- Caution: Patients prescribed anti-inflammatory drugs may have an _____ effect
```
Aminosalicylic acid
twice
Mesalazine
Sulphasalazine
Balsalaside
anti-inflammatory
inflammatory cytokines
arachidonic acid metabolite
PG synthesis
Nausea
yellow-orange
folate
remission
compliance
additive
```
38
inflammatory bowel disease (IBD)
- idiopathic disease
- dysfunction of the _____ and _____ immune system
- two major types:
- -ulcerative colitis (US): limited to the _____ mucosa
- -crohns disease (CD): affects any segment of GIT from _____ to _____, involves _____ lesions and is _____
-there is a genetic predisposition for IBD, and patients are more prone to development of _____
```
innate
adaptive
colonic
mouth
anus
skip
transmural
malignancy
```
39
h2 blockers pharmacokinetics
- undergo _____ metabolism resulting in bioavailability of _____ (except _____)
- action starts within an _____ and DOA is _____ hours based on the dose administered
- ADRs: _____, _____, _____, _____, _____ and _____
- these drugs are cleared by combination of _____ metabolism, _____ filtration, and _____ secretion
- dose reduction is required in patients with moderate to severe _____ and _____ insufficiency
- in the elderly, a decrease in _____ and _____ decline in drug clearance occurs
```
first pass hepatic
50%
Nizatidine
hour
8-12
xerostomia
diarrhea
myalgia
headache
constipation
fatigue
hepatic
glomerular
renal tubular
renal
hepatic
volume of distribution
50%
```
40
PUD treatment
- Address the underlying cause
- Lifestyle changes:
- Reduction in _____ and _____ foods
- _____ loss
- Head of bed _____ & avoidance of meals _____ before _____
- Eradication of _____ infection
- Withdraw _____
- Anti-secretory therapy
1: _____
2: _____ blockers
3: _____ inhibitors (PPIs)
```
fatty
spicy
weight
elevation
2-3 hours
bedtime
H pylori
NSAIDs
Antacids
H2
proton pump
```
41
symptoms of IBD
- Abdominal cramping and pain- Commonly in _____ in CD and in _____ or _____ in UC
- Irregular bowel habits, passage of _____ with/without blood or pus, _____
- Weight loss, _____ (during flare-up)
- _____, _____, _____
- _____ (50%)
- Perianal disease (_____, _____): 50% patients with CD
- _____ and delayed or failed _____ maturation in children
- Malabsorption of _____, _____ and other nutrients leading to _____ and _____ lesions
```
RLQ
periumbilical
LLQ
mucus
tenesmus
Fever
Malaise
Arthralgia
Uveitis
Pyoderma gangrenosum
fistulas
abscesses
Growth retardation
sexual
iron
B12
anemia
oral
```
42
proton pump inhibitors- most potent
-Given orally: _____ (Prilosec), _____ (Prevacid), _____ (Protonix)
-Are _____ that require gastric acid secretion to be converted to the active _____ or _____.
-_____ bioavailability is high (77% to 90%) and show equivalent efficacy
-Bind to the _____ irreversibly
-Half-life is about _____ hour (9 hours for Tenatoprazole, but the duration of acid inhibition is _____ hours (pumps take around 50 hours to resynthesize)
-Most PPIs are metabolized by CYP2C19 and CYP3A4.
__________ and ______ reduce clearance of the PPIs, as do mutations in CYP2C19.
```
Omeprazole
Lansoprazole
Pantoprazole
prodrugs
Sulfenamide
Sulfenic acid
Oral
H,K-ATPase
1
48
hepatic impairment, old age
```
43
irritable bowel syndrome
- abdominal pain or discomfort accompanied by a change in _____ habit and an abnormal _____ frequency:
- -_____ is a>3 bowel movement/day
- -_____ is <3 movements/week
- prevalence is 10-15%
- more common in _____ 2:1
- often coexists with other GI disorders, both functional (_____, chronic _____) and organic (_____ disease, _____, _____)
```
bowel
stool
diarrhea
constipation
women
dyspepsia
constipation
celiac
GERD
IBD
```
44
STEP 1A- ANTIBIOTICS
- Used more often for _____ disease, _____, _____ masses in CD
- Most commonly used antibiotics are :
- -_____
- -_____
```
perianal
fistulas
intra-abdominal inflammatory
Ciprofloxacin
Metronidazole
```
45
GERD and extra-esophageal symptoms
- Refluxed gastric contents can go into the throat, airways and lungs causing irritation or damage:
- -Chronic _____
- -Chronic _____
- -_____
- -_____
- Progressive breathing problems
- Pulmonary diseases (adult-onset _____ or pulmonary _____)
-Distinguish _____ from _____ chest pain before diagnosing GERD
```
cough
laryngitis
aspiration
pneumonia
asthma
fibrosis
cardiac
non-cardiac
```
46
h2 blockers clinical relevance
- use of H2 blockers before treatment ( _____ premedication/surgeries) is beneficial in _____ patients
- _____ and _____ may occasionally cause thrombocytopenia
- GI pH is _____, concurrent use causes marked reduction in absorption of _____. advise patients to take at a different time.
- _____ alters the blood flow to the liver and is an enzyme inhibitor: can enhance DOA of other medications, especially _____
- cimetidine inhibits the metabolism of _____ and _____
```
anesthetic
GERD
cimetidine
ranitidine
increased
antifungals
cimetidine
analgesics
phenytoin
warfarin
```
47
symptoms of PUD
- _____ stomach pain
- feeling of _____
- _____ or _____
- _____ food intolerance
- _____
- _____
- gastric ulcer- pain is _____ after _____
- duodenal ulcer- _____ after meals
- etiology is similar to _____
- _____ alone do not increase the risk for PUD, can potentiate _____ risk in patients who use _____ concurrently
```
burning
fullness
bloating
belching
fatty
heartburn
nausea
shortly
meals
2-3 hours
meals
gastritis
corticosteroids
ulcer
NSAIDs
```
48
traveller's diarrhea
- DD: _____ (e.g., Staphylococcus aureus, Bacillus cereus)
- _____ prohylaxis : Not recommended
- Avoid high-risk _____ (street vendors) and eating behaviors (cold sauces, salsas)
- Empiric treatment:
- -_____ solutions (sometimes change in H20 and electrolyte imbalance is the cause of diarrhea)
- -_____ agonists – Increase colonic transit time (anti-_____) and Increase fecal water absorption (anti-______)
- _____ (does not cross BBB so no addiction potential), has _____ effects
- _____ + _____ (Lomotil), CNS effects at higher doses
- _____ - Rifaximin (Salix), also used in IBS as has anti-inflammatory and antibacterial properties
```
Gastroenteritis
Antibiotic
foods
Oral rehydration solutions
Opioid agonists
motility, secratory
Loperamide
anticholinergic
Diphenoxylate
atropine
Antibiotics
```
49
GI diseases
Esophagus –_____ (_____)
Stomach – _____, _____ (PUD)
Intestines –
-Acute: _____ (Bacteria, Viruses and Protozoa) / Traveler’s _____
Chronic: _____ (duodenum), _____ diseases (IBD- UC/Crohn’s), _____ (_____), and _____ disease
-_____
Rectum and Anus – Anal fissures, _____
```
Gastroesophageal reflux disease (GERD)
gastritis
peptic ulcer disease
Gasteroenteritis
diarrhea
Peptic ulcer disease
Inflammatory bowel
Irritable bowel syndrome (IBS) Coeliac
constipation
Hemorrhoids
```
PAS - PHARM
flashcards
Decks in class (26)
# Cards
-
Clinical Trials and New Drug Development4
-
Pharmacokinetic Principles of Pharmacology54
-
Autonomic Pharmacology42
-
Respiratory39
-
GI49
-
Respiratory 222
-
Cardiovascular System and Drugs34
-
Part 2 CVS drugs27
-
Heart Failure22
-
Antiarrythmics24
-
Hyperlipidemias22
-
extra17
-
Anticancer Drugs49
-
chemotherapy part 114
-
chemotherapy part 1 (2)14
-
chemotherapy part 1 (3)10
-
chemotherapy part 1 (4)15
-
chemotherapy part 221
-
CNS: ANTIPSYCHOTICS18
-
CNS: ANTI-SEIZURE DRUGS17
-
Parkinson's Disease16
-
Diabetes22
-
CNS affective disorders part 218
-
CNS disorders part 125
-
Pain, Inflammation and Anti-Inflammatory43
-
ANTICOAGULANTS, ANTIPLATELET DRUGS, FIBROLYTIC AGENTS PART 217
